Improved growth of stromal cells in long term bone marrow cultures (LTBMC) of myelodysplastic syndrome (MDS) patients treated with thalidomide.

被引：0
|
作者：
Alvi, S
Shaher, A
Henderson, B
Dar, S
Zorat, F
Broderick, E
Lisak, L
Du Randt, M
Reddy, P
Mundle, S
Galili, N
Borok, RZ
Raza, A
机构：
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1547
引用
收藏
页码：359A / 359A
页数：1
相关论文
共 50 条
  • [1] Depletion of lymphocytes increases the in vitro hemopoiesis in long term bone marrow cultures (LTBMC) from patients with myelodysplastic syndrome (MDS): Implications for the immunosuppressive therapy of MDS.
    Scheid, C
    Baumann, I
    Koref, MS
    Swindell, R
    Testa, NG
    Stern, PL
    Dexter, TM
    BLOOD, 1999, 94 (10) : 390A - 390A
  • [2] Cytogenetic and clonal profile of myelodysplastic syndromes (MDS) patients treated with thalidomide.
    Alvi, S
    Shaikh, M
    Anthwal, S
    Shaher, A
    Tamoseviciene, D
    Novick, A
    Reddy, P
    Allampallam, K
    Hsu, WT
    Galili, N
    Borok, RZ
    Raza, A
    BLOOD, 2001, 98 (11) : 352A - 352A
  • [3] Thalidomide significantly modifies bone marrow microenvironment in myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Borok, RZ
    Shaher, A
    Anthwal, S
    Shaikh, M
    Alvi, I
    Tahir, S
    John, P
    Shetty, V
    Galili, N
    Raza, A
    BLOOD, 2002, 100 (11) : 375A - 375A
  • [4] Thalidomide significantly augments proliferation and cytokine secretion in bone marrow cultures established from myelodysplastic syndrome (MDS) patients.
    Alvi, S
    Anthwal, S
    Shaikh, M
    Shaher, A
    Shetty, V
    Mundle, S
    Reddy, P
    Allampallam, K
    Bi, SC
    Zorat, F
    Tamosveiciene, D
    Rasila, K
    Meagher, R
    Westbrook, C
    Galili, N
    Gezer, S
    Venugopal, P
    Borok, RZ
    Raza, A
    BLOOD, 2001, 98 (11) : 352A - 352A
  • [5] THE GROWTH OF MYELODYSPLASTIC BONE-MARROW IN LONG-TERM CULTURES
    BORBENYI, Z
    CINKOTAI, C
    HARRISON, C
    TESTA, NG
    BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 291 - 293
  • [6] Regulation of the osteogenic potential of long-term bone marrow cultures (LTBMC).
    Fuller, JA
    Long, MW
    BLOOD, 2000, 96 (11) : 72A - 72A
  • [7] DETECTION OF LATENT SUBCLONE WITH ABNORMAL KARYOTYPE BY LONG-TERM BONE-MARROW CULTURES OF MYELODYSPLASTIC SYNDROME (MDS)
    TAMURA, S
    KANAMARU, A
    OKAMOTO, T
    KAKISHITA, E
    NAGAI, K
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 566 - 566
  • [8] Effects of thalidomide on long-term bone marrow cultures from patients with myelodysplastic syndromes: Induction of IL-10 expression in the stromal layers
    Lazarini, Mariana
    Traina, Fabiola
    Winnischofer, Sheila M.
    Costa, Fernando F.
    Queiroz, Mary Luci S.
    Saad, Sara T. Olalla
    LEUKEMIA RESEARCH, 2011, 35 (08) : 1102 - 1107
  • [9] FUNCTIONAL-STUDIES OF BONE-MARROW HEMATOPOIETIC AND STROMAL CELLS IN THE MYELODYSPLASTIC SYNDROME (MDS)
    COUTINHO, LH
    GEARY, CG
    CHANG, J
    HARRISON, C
    TESTA, NG
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 75 (01) : 16 - 25
  • [10] LONG-TERM BONE-MARROW CULTURES (LTBMC) IN PATIENTS WITH CGL BEFORE AND AFTER BMT
    MICHALLET, M
    LEGER, J
    CHABANNON, C
    COUSIN, F
    CHAUVET, M
    STEPHANY, I
    LEROUX, D
    LAJMANOWITCH, A
    HOLLARD, D
    BONE MARROW TRANSPLANTATION, 1988, 3 : 195 - 195
12345